| Financial Year |
March 31 2023 |
| Monetary Funds |
485,537,595.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,278,703.99 |
| Accounts Receivable |
143,566,720.75 |
| Advances to Suppliers |
16,071,411.62 |
| Other Receivables |
4,866,142.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,091,395.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,307,761.96 |
| Total Current Assets |
835,983,129.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
11,328,572.29 |
| Fixed Assetes |
646,151,322.54 |
| Under-construction Projects |
63,046,207.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,255,317.13 |
| R&D expenses |
97,752,831.72 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,383,621.61 |
| Deferred Income Tax Assets |
24,351,522.95 |
| Other Non-Current Assets |
50,608,984.64 |
| Sub-Total of Non-Current Assets |
993,174,392.49 |
| Total Assets |
1,829,157,522.20 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,242,515.38 |
| Accounts Received In Advance |
221,096.42 |
| Employee Compensation Payable |
51,001,052.54 |
| Taxes Payable |
4,275,356.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
73,163,781.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,960,753.03 |
| Other Current Liabilities |
11,595,722.96 |
| Sub-Total of Current Liabilities |
174,667,629.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,347,839.85 |
| Total Liabilities |
250,015,468.98 |
| Paid-In Capital(Or Share Stock) |
88,555,082.00 |
| Capital Surplus |
859,840,957.04 |
| Surplus Reserve |
44,277,541.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
586,468,473.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,579,142,053.22 |
| Owner's Equity（Stockholder's Equity） |
1,579,142,053.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,829,157,522.20 |
